Visit the Knudra/NemaMetrix joint booth at the 21st International C. elegans Meeting to learn latest trends and applications in C. elegans research. Also, stop by for a chance to win a daily prize! Answer a [...]
NemaMetrix’s ScreenChip collects live-animal, high-throughput C. elegans elecropharyngeograms (EPGs), which are an indication of overall organism health for drug development. Read the blog post on BioCoder published by O'Reilly Bio.
NemaMetrix is sponsoring the 2017 Bay Area Worm Meeting at Mission Bay Campus of the University of California, San Francisco, at 600 16th Street, San Francisco, CA 94158, in Genentech Hall. We will be [...]
Eugene, OR. — October 10, 2016 Nemametrix Inc., a fast-growing life sciences startup that created the innovative ScreenChip System for drug screening, mutant phenotyping, and toxicological assessment, has entered into a co-marketing partnership with Knudra Transgenics, [...]
Now Available! ScreenChip for L1 stage. Test EPGs in the L1 stage with the NemaMetrix ScreenChip 10. This device enables researchers to quantitatively study EPG waveforms and phenotypes at an earlier developmental timepoint than has [...]
Come and visit our team at the Aging, Metabolism, Pathogenesis, Stress, and Small RNAs in C. elegans conference in Madison, Wisconsin! We'll be showing live demos and discussing the results of our most recent research with the [...]
NemaMetrix will be attending the The Allied Genetics Conference (TAGC) on July 13-17, 2016. For the first time, researchers studying C. elegans, Drosophila, mouse, zebrafish, yeast, ciliates, and PEQ will be holding meetings under the [...]
NemaMetrix is pleased to announce that we will be attending the 2016 European Worm Meeting in Berlin on June 1-3, 2016. Attending a European conference is a unique opportunity for us to hear about the [...]
Mike Harris working with the NemaMetrix ScreenChip system during a customer workshop. At our inaugural ScreenChip Workshop, one of our very first customers, Dr. Mike Harris, had a burning question. He'd been collaborating for years on [...]
Recently, NemaMetrix hosted its inaugural ScreenChip workshop in Eugene, OR. A diverse group of researchers gathered together for a three-day workshop to learn about our technology. Food, lodging and transportation were provided for our guests [...]
NemaMetrix had the wonderful opportunity to connect with many people in the worm community at the 2015 Worm Meeting in Los Angeles. From aging to imaging, drug screening to mutant phenotyping, it was [...]
Our Co-founder, Dr. Weeks, gave an impassioned scientific talk in Gabon, discussing her work at the University of Oregon that led her to starting NemaMetrix and receiving a Bill & Melinda Gates Foundation grant for [...]
January 28, 2014 – NemaMetrix announces being awarded $188,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health. The funds will be used to support fundamental proof of concept research, [...]
NemaMetrix announces being awarded $249,000 in GAP funding from Oregon Nanoscience and Microtechnologies Institute (ONAMI) to fund “proof-of-concept” work and to fuel development towards commercialization.